Patents by Inventor Timothy Patrick Boyle

Timothy Patrick Boyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROREACTORS FOR SEPARATION OF HETEROGENEOUS LIQUIDS
    Publication number: 20130233807
    Abstract: A microreactor for separating heterogeneous liquids including a series or baffles and passageways is disclosed herein along with a methods for using such microreactors, and methods for manufacturing such microreactors.
    Type: Application
    Filed: March 6, 2012
    Publication date: September 12, 2013
    Applicant: EMPIRE TECHNOLOGY DEVELOPMENT LLC
    Inventor: Timothy Patrick Boyle
  • Peptidic compounds
    Patent number: 8524657
    Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 3, 2013
    Assignee: University of Wollongong
    Inventors: Timothy Patrick Boyle, John Barnard Bremmer, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • PEPTIDIC COMPOUNDS
    Publication number: 20110312875
    Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Application
    Filed: August 2, 2011
    Publication date: December 22, 2011
    Applicant: UNIVERSITY OF WOLLONGONG
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • Peptidic compounds
    Patent number: 8039430
    Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: October 18, 2011
    Assignee: University of Wollongong
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • Peptidic Compounds
    Publication number: 20080300287
    Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Application
    Filed: September 21, 2005
    Publication date: December 4, 2008
    Applicant: UNIVERSITY OF WOLLONGONG
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson